Universitair Ziekenhuis Brussel
Brussels, 1090, Belgium
NCT Number: NCT01682057
The purpose of this study is to evaluate the safety and performance of the ROX Anastomotic Coupler System (ACS) in patients with severe hypertension.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 2
Brussels, 1090, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The ROX Anastomic Coupler (ACS) will be used to create an arteriovenous fistula in the iliac region (between the iliac artery and vein).
Time frame: Baseline, 6 months
Change in mean office SBP at six months as compared to Baseline
Time frame: Change in mean office DBP six months as compared to Baseline
Change in mean office DBP at six months as compared to Baseline
ROX Medical, Inc.
Industry
A Prospective, Non-Randomized, Open Label, Multi-Center Study to Evaluate the ROX Anastomotic Coupler System (ACS) in Patients With Severe Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02055209
Cardiovascular Diseases, Hypertension
Bethesda, Maryland, United States
View Trial DetailsNCT02692846
Aortic Stenosis, Supravalvular, Aortic Valve Disease
Bethesda, Maryland, United States
View Trial DetailsNCT07747363
Cardiovascular Diseases, Chronic Disease
Austin, Texas, United States
View Trial DetailsNCT07432893
Body Temperature Changes, Breathlessness
Birbhum, West Bengal, India
View Trial Details